The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term safety and overall survival update for BREAK-2, a phase 2, single-arm, open-label study of dabrafenib in previously treated metastatic melanoma (NCT01153763).
Paolo Antonio Ascierto
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche/Genentech; Ventana
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Roche/Genentech
Research Funding - Bristol-Myers Squibb; Ventana
David R. Minor
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Antoni Ribas
Consultant or Advisory Role - Amgen; Genentech; GlaxoSmithKline; Merck
Stock Ownership - Kite Pharma
Celeste Lebbe
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Roche
Anne O'Hagan
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
R. Suzanne Swann
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Anita Scheuber
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Other Remuneration - GlaxoSmithKline
Dirk Schadendorf
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Roche
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Roche
Richard Kefford
Consultant or Advisory Role - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Other Remuneration - GlaxoSmithKline
Jean Jacques Grob
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck; Roche
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Omid Hamid
Research Funding - GlaxoSmithKline
Lynn Mara Schuchter
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Merck
Ester Simeone
No relevant relationships to disclose
Tabea Wilhelm
No relevant relationships to disclose
Kevin Kim
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Gursel Aktan
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline (I); GlaxoSmithKline
Uwe Trefzer
Consultant or Advisory Role - GlaxoSmithKline; Merck Sharp & Dohme; Roche
Honoraria - GlaxoSmithKline; Roche